SCHEMBL18673156

SCHEMBL18673156

CCC1C(O)C(C)C2C(=O)N(CC3CCCCC3CN3CCN(C4=NS(=O)(=O)c5ccccc54)CC3)C(=O)C12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 3/20 0.43
POLB P06746 2/20 0.41
LDHA P00338 1/20 0.40
HTR2B P41595 2/20 0.40
DRD2 P14416 2/20 0.40
ADRA2C P18825 2/20 0.40
HTR2A P28223 2/20 0.40
ABCB11 O95342 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADRA2B P18089 1/20 0.40
DRD1 P21728 1/20 0.40
TBXA2R P21731 1/20 0.40
ACHE P22303 1/20 0.40
SLC6A2 P23975 1/20 0.40
PDE4A P27815 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16804116 0.85 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2TSHRPOLBLDHA
SCHEMBL19084395 0.81 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TSHRPOLBLDHA
SCHEMBL19084426 0.79 HTR2B (0.55) ALDH1A1SMN1; SMN2TSHRPOLBLDHA
SCHEMBL18673181 0.77 DRD2 (0.69) HTR2BDRD2ADRA2CHTR2AABCB11
SCHEMBL18673134 0.68
SCHEMBL19084396 0.66 HTR2B (0.34) ALDH1A1POLBHTR2BDRD2ADRA2C
SCHEMBL10469851 0.64 SMN1; SMN2 (0.67) ALDH1A1SMN1; SMN2TSHRPOLBSORD
SCHEMBL16229130 0.63 DRD2 (0.62) ALDH1A1SMN1; SMN2HTR2BDRD2ADRA2C
SCHEMBL12445891 0.63 DRD2 (0.62) ALDH1A1SMN1; SMN2HTR2BDRD2ADRA2C
SCHEMBL27596185 0.63 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TSHRPOLBLDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9606132-B2 Methods of monitoring adherence to lurasidone therapy AMERITOX, LTD. (US) 2017-03-28 US disclosed